<DOC>
	<DOCNO>NCT02758067</DOCNO>
	<brief_summary>To demonstrate effectiveness brexpiprazole ( 2-4 mg/day ) quality life non-inferior risperidone ( 4-6 mg/day ) adult patient schizophrenia .</brief_summary>
	<brief_title>Comparison Effectiveness Brexpiprazole With That Risperidone</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>The patient schizophrenia diagnose accord DSM5™ The patient first formal diagnosis schizophrenia le 10 year ago The patient prescribe outpatient oral antipsychotic treatment recommend dose range state Summary product characteristic equivalent document/label full 3 month prior Screening Visit . The patient CGIS score 3 ( mildly ill ) 4 ( moderately ill ) Screening Baseline Visits . The patient Global Assessment Scale ( GAS ) score 41 70 ( limit include ) Screening Baseline Visits . The patient need change current antipsychotic treatment due insufficient functional improvement , judgement investigator , would benefit switch another treatment . Reasons switch include limited following reason : 1. lack adequate response current antipsychotic medication , 2. poor tolerability current antipsychotic medication , 3. unwillingness patient adhere current antipsychotic medication . The patient psychiatric disorder ( DSM5™ criterion ) schizophrenia establish primary diagnosis . The patient experience acute exacerbation psychotic symptom Screening Visit , Screening Baseline Visits Baseline Visit . The patient hospitalise psychotic symptom Screening Visit , Screening Baseline Visits Baseline Visit . The patient treat brexpiprazole , risperidone clozapine time Screening Visit . The patient show , investigator 's judgment , significant lack efficacy brexpiprazole , risperidone paliperidone treat recommend dose range state respective Summary product characteristic equivalent document/ label , manner would preclude benefit study medication randomise brexpiprazole risperidone study . The patient consider resistant antipsychotic treatment accord investigator 's judgement . The patient significant risk harm himself/herself , others accord investigator 's judgement base Columbia Suicide Severity Rating Scale ( CSSRS ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>